In May 2011, Nuvo acquired ZARS Pharma, Inc., a company with several novel proprietary pain drug delivery technologies, including Controlled Heat-Assisted Drug Delivery (CHADD™) technology, Peel™ drug delivery technology and DuraPeel™ technology.
The CHADD technology utilizes the application of controlled heat to enhance transdermal absorption of drugs which we believe can have a number of benefits, including more effective dosing, faster onset of action, reduced side effects, broader applicability and complementary therapeutic combination of drug and heat. CHADD drug delivery technology can be utilized for both topical, i.e. local, drug delivery, as well as transdermal systemic drug delivery.
The Peel and DuraPeel technologies allow drugs to be administered as a cream that dries to form a pliable solid layer, offering potential advantages over traditional creams, gels and lotions including better controlled drug delivery, increased patient compliance and easier application and removal to large and irregular skin surfaces.